MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis

Area of Science:

• Nephrology
• Immunology
• Molecular Biology

Background:

• Lupus nephritis (LN) significantly increases morbidity and mortality in systemic lupus erythematosus (SLE) patients.
• Reliable biomarkers are crucial for the early diagnosis and management of LN.
• MicroRNAs (miRNAs) are increasingly recognized as potential biomarkers and therapeutic targets in LN.

Purpose of the Study:

• To investigate the role of microRNA-203 in the development and progression of lupus nephritis.
• To evaluate the diagnostic potential of circulating microRNA-203 as a biomarker for LN in clinical practice.

Main Methods:

• Serum samples were collected from 40 participants: 20 with SLE and 20 with LN, diagnosed according to ACR 1997 criteria.
• MicroRNA-203 expression levels were quantified using real-time Polymerase Chain Reaction (PCR).
• Statistical significance was assessed using the Mann-Whitney test.

Main Results:

• MicroRNA-203 expression was significantly higher in patients with LN (median 5.18) compared to those with SLE (median 1.66).
• The difference in microRNA-203 expression between the two groups was statistically significant (p=0.003).

Conclusions:

• Circulating microRNA-203 expression levels are elevated in patients with lupus nephritis.
• MicroRNA-203 may be a potential biomarker associated with nephritis manifestations in SLE patients.
• Further research is warranted to confirm the clinical utility of microRNA-203 in LN diagnosis and management.